Core Scientific stock falls around 4.5% as technical selling pressure dominates

Core Scientific stock falls around 4.5% as technical selling pressure dominates
Core scientific slides 4.55% today

Core Scientific Inc. (CORZ) sold off 4.55% today amid persistent technical selling pressure, as confirmed by momentum indicators and a clear bearish trend. The downside move is reinforced by the price holding below all major moving averages, signaling that sellers retain control across all timeframes.

CORZ price prediction
24H -0.98%
$13.12
48H -2.57%
$12.91
7D -1.51%
$13.05
1M -30.94%
$9.15
3M -51.62%
$6.41
6M -53.74%
$6.13
12M -50.57%
$6.55
Current price: $13.25 -1.1570 8.03%
Closed 10/30
Daily range 12.78 Arrow from to Icon 13.68
Weekly range 12.65 Arrow from to Icon 15.01
Loading...

Highlights

  • Core Scientific stock trades below key moving averages across all timeframes, confirming a prevailing bearish trend.
  • Momentum indicators show sustained selling pressure with the stock approaching but not fully reaching oversold conditions.
  • The stock is projected to move within a $15.14 to $16.91 range in the next five days, with downside risk remaining dominant.
Anton Kharitonov, expert at Traders Union, sees clear technical weakness dominating Core Scientific. The price remains suppressed under every major moving average, and momentum readings show no relief from sustained selling. He notes the absence of supportive news, which further undermines any near-term recovery hopes. Resistance at $16.53 and fragile support at $15.55 leave the asset exposed to deeper downside. "Technical and sentiment signals point to a strong bearish grip — any rebound attempts are likely to fail unless clear catalysts emerge," Kharitonov says.
Viktoras Karapetjanc, expert at Traders Union, maintains a constructive view despite the recent price pressure. He sees the current technical setup as a temporary setback within a larger opportunity zone. The absence of negative headlines may allow sentiment to stabilize, and he emphasizes the strong interest around key support. "I expect buyers to regroup for a push above $16.53 soon — the market structure offers compelling setups for renewed upside," Karapetjanc states.
Jainam Mehta, market strategist, observes that Core Scientific is at an inflection point. The price is boxed between established support and resistance, with indicators approaching oversold but not yet extreme. He notes that a quick move in either direction could offer tactical entries. "If momentum turns above $16.53, I’d watch for a breakout play — but a drop below $15.14 strengthens the bearish case," Mehta adds.
Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Sustained weakness as indicators confirm broad-based bearish pressure

Core Scientific is trading below all major moving averages, with the price under the 20-day ($17.21), 50-day ($18.39), and 200-day ($19.82) levels. This setup signals sustained selling forces dominating short-, medium-, and long-term horizons, with a bearish longer-term trend fully established. Immediate resistance appears at $16.53, while support is marked by the current week’s low of $15.55. Momentum remains weak: the MACD and ADX both highlight ongoing selling, while the RSI at 43.8, CCI at -52.37, and Stochastic RSI at 36.39 suggest conditions are nearing, but not reaching, oversold status. Bull/Bear Power is marginally positive at 0.05, pointing to slight intraday buyer interest, and the Awesome Oscillator gives a neutral signal. The trading session opened with a minor upward gap but reversed into losses, closing near session lows with evident broad-based selling pressure.

Earlier, analysts noted that Core Scientific faced a consolidating range with a bias toward increased downside risk based on mixed technical signals. The latest trading session reinforces this view, with persistent selling pressure and multi-timeframe bearish momentum making the $15.14 level a critical support to monitor for any further downside break.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.